Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Eli Lilly lops Alzheimer's and obesity assets from pipeline
Eli Lilly has thinned its pipeline in two critical areas, axing clinical-phase Alzheimer’s and obesity candidates as part of its quarterly clear-out.
Nick Paul Taylor
Feb 6, 2025 9:16am
AstraZeneca CEO defends 'fantastic' Alexion buy as halts drug
Feb 6, 2025 6:45am
GSK drops 1 potential 'cure' for hep B, focuses on bepirovirsen
Feb 5, 2025 6:00am
Novartis gives up on anti-CD40 antibody to treat Sjögren's
Jan 31, 2025 5:13am
Sanofi cuts programs tied to multibillion-dollar deals
Jan 30, 2025 9:05am
Roche drops HER2 bispecific, Xencor-partnered cytokine
Jan 30, 2025 4:56am